跳至主要内容
临床试验/NL-OMON28957
NL-OMON28957招募中不适用

A randomized controlled trial to investigate the efficacy of a multispecies probiotic supplement (Ecologic® BARRIER) on symptoms of fatigue in subjects with Inflammatory Bowel Disease

Winclove B.V.0 个研究点目标入组 230 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
230

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects between the ages of 18 and 65 years old.
  • Subjects diagnosed with Crohn’s disease or Ulcerative Colitis.
  • Subjects with a score of 4 or higher on the Chalder Fatigue Questionnaire.

排除标准

  • Subjects with active inflammation. Disease has to be in remission defined as CRP = 10 mg/l, leucocytes between 4.0-10.0 10E9/l and calprotectin levels of = 100 µg/g.
  • Subjects with abnormal laboratory values, including but not limited to hemoglobin, vitamin B12 and folic acid levels. These need to be corrected and retested before entering the study.
  • Subjects who used probiotics (including probiotic-containing products such as Yakult, Actimel, etc), antibiotics or Non-Steroidal Anti- Inflammatory Drugs (NSAIDs) in the 4 weeks prior to the screening visit, or are planning to do so during the study.
  • Subjects with local manifestation of IBD for which surgery might be indicated or which could confound the evaluation of efficacy.
  • Subjects who have had placement of a stoma or pouch.
  • Subjects who are pregnant, lactating or planning pregnancy while enrolled in the study.
  • Subjects who are unsuitable for inclusion in the study in the opinion of the investigator for any reason that may compromise the subject’s safety or confound data interpretation.

研究者

发起方
Winclove B.V.

相似试验